Sage Journals: Discover world-class research

Free access

Review article

First published 2010-07

Review: Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects

Diogo Assed Bastos, Suilane Coelho Ribeiro, Daniela de Freitas [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2013-5

Cost-Effectiveness of Adjuvant FOLFOX and 5FU/LV Chemotherapy for Patients with Stage II Colon Cancer

Mehmet U. S. Ayvaci, Jinghua Shi, Oguzhan Alagoz [...]

Medical Decision Making

Retricted access

Research article

First published 2025-4

Tumour Budding Is a Useful Predictor to Identify High-Risk Stage II Colon Cancer Patients After Curative Surgery

Mehmet Zengin, Özlem Tanas Işıkçı

International Journal of Surgical Pathology

Open access

Research article

First published 2021

Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients

Gabrielle Jongeneel, Marjolein J. E. Greuter, Felice N. van Erning [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2019

De-escalating chemotherapy for stage II colon cancer?

Jianfei Fu, Lunpo Wu, Chenyang Ge [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2012-10

A Seven-Gene Signature Aggregates a Subgroup of Stage II Colon Cancers with Stage III

Sophy Laibe, Arnaud Lagarde, Anthony Ferrari [...]

OMICS: A Journal of Integrative Biology

Free access

Research article

First published 2017-07

Use of a Combination of CEA and Tumor Budding to Identify High-risk Patients with Stage II Colon Cancer

Changzheng Du, Weicheng Xue, Fangyuan Dou [...]

The International Journal of Biological Markers

Free access

Research article

First published 2016-11

Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer

Zhiliang Huang, Zenan Ai, Nan Li [...]

Cancer Biomarkers

Open access

Research article

First published 2021-3

Low levels of BRCA1 protein expression predict a worse prognosis in stage I–II colon cancer

Changzheng Du, Yifan Peng, Yiping He [...]

The International Journal of Biological Markers

Retricted access

Research article

First published 2014-03

Do High-risk Features Support the Use of Adjuvant Chemotherapy in Stage II Colon Cancer? A Turkish Oncology Group Study

Mehmet Artac, Nazim Serdar Turhal, Murat Kocer [...]

Tumori Journal

Search results